HCC group 2 (n = 40) | Â | Â | Â | Â |
---|---|---|---|---|
Mutation (1613/1653) | -/- | +/- | -/+ | +/+ |
n | 14 | 6 | 6 | 14 |
HBeAg (positive) | 40% | 60% | 50% | 67% |
Sex (Male) | 79% | 83% | 83% | 71% |
Patient age | 54.6 ± 14.3- | 43.3 ± 6.7 | 57.8 ± 18.3 | 57.8 ± 9.5 |
Non-HCC group 2 (n = 52) | Â | Â | Â | Â |
Mutation (1613/1653) | -/- | +/- | -/+ | +/+ |
n | 43 | 3 | 3 | 3 |
HBeAg (positive) | 78% | 50% | 33% | 100% |
Sex (Male) | 81% | 100% | 67% | 100% |
Patient age | 37.8 ± 11.0 | 32.0 ± 17.3 | 48.7 ± 7.0 | 30.7 ± 10.2 |